At a glance
Genworth Financial Inc is worth $3.36B, about 16 times its fiscal 2025 earnings. Revenue grew 0.1% to $7.30B in fiscal 2025, with 3.1% kept as profit; over 5 years it has grown 2.5% a year. It pays no dividend; it spent $796.0M buying back its shares over FY2021–FY2025. The stock returned +5.7% over the past year with dividends reinvested and +15.6% a year over five years, against +11.5% and +11.7% for the S&P 500. At its worst it fell 37.9% in the 2020 crash (S&P 500: 33.7%) and 22.0% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 32 months and 4 months after the lows.
The business in plain English
Genworth Financial is an insurance holding company. Its main active business is private mortgage insurance. It sells this through Enact Holdings, which trades on Nasdaq as ACT but is controlled by Genworth. Enact has offered this coverage in the United States since 1981. It protects lenders and investors, mainly Fannie Mae and Freddie Mac, against losses when a borrower stops paying on a loan worth more than 80% of the home's value.
Most revenue comes from the Closed Block. These are long-term care, life insurance and annuity policies that Genworth's older insurers no longer sell but still manage. In fiscal 2025 the Closed Block produced $5.96 billion, or 81.6% of $7.3 billion in total revenue. Enact produced $1.25 billion, or 17.1%. The Closed Block runs on its own. It relies on its reserves (money set aside for claims) and on premium increases for long-term care policies. Genworth looks to Enact for cash, and Enact returned $407 million to Genworth's holding company in 2025.
Genworth's growth bet is CareScout. CareScout Services connects families with about 790 home care providers and sells care assessments and care plans. In October 2025 it acquired Seniorly, a platform that helps families find senior living. Also in October 2025, CareScout Insurance began selling a new long-term care policy, Care Assurance. It was available in 40 states as of February 20, 2026.
Price history
The interactive chart needs JavaScript.
GNW +5.7% over the year to Oct 28, 2026, total return with dividends reinvested.
How it makes money
By business segment
| Closed Block | $5.96B | 81.6% |
| Enact segment | $1.25B | 17.1% |
Latest results
- In Q2 FY2026 (ended Jun 30, 2026), revenue was $1.90B, up 5.8% from a year earlier, and net income was $47.0M (-7.8%).
- For fiscal 2025, revenue was $7.30B (+0.1% year over year; -2.5% a year from FY2020 to FY2025) with a 3.1% net margin.
Financial health check
| Revenue growth a year (FY2020–FY2025) | -2.5% weak |
|---|---|
| Return on equity (FY2025) | 2.5% weak |
| Return on assets (FY2025) | 0.3% weak |
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2020 | $8.28B | $178.0M | — |
| FY2021 | $7.82B | $850.0M | — |
| FY2022 | $7.50B | $916.0M | — |
| FY2023 | $7.49B | $76.0M | — |
| FY2024 | $7.29B | $299.0M | — |
| FY2025 | $7.30B | $223.0M | — |
Valuation snapshot
| Market value | $3.36B |
|---|---|
| P/E ratio | 16.4 |
| Dividend yield | 0% |
Rank among 1514 US companies
Market value at each year end
Genworth Financial’s market value went from $1.90B at the end of 2016 to $3.36B on Oct 28, 2026, up 77%; since the end of 2025 it is down 7%.
Show as a table
| Year end | Market value | Change |
|---|---|---|
| Oct 28, 2026 | $3.36B | -7.0% |
| 2025 | $3.61B | +20.8% |
| 2024 | $2.98B | -0.9% |
| 2023 | $3.01B | +14.7% |
| 2022 | $2.63B | +27.8% |
| 2021 | $2.05B | +7.5% |
| 2020 | $1.91B | -13.7% |
| 2019 | $2.22B | -5.1% |
| 2018 | $2.33B | +50.3% |
| 2017 | $1.55B | -18.2% |
| 2016 | $1.90B |
Price behavior
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|---|
| GNW price data to Oct 28, 2026 | -1.7% | +5.7% | +15.2% | +15.6% | +8.4% |
Show as a table
| Year | Price data |
|---|---|
| 2026 (to date) | -1.7% |
| 2025 | +29.2% |
| 2024 | +4.6% |
| 2023 | +26.3% |
| 2022 | +30.6% |
| 2021 | +7.1% |
| 2020 | -14.1% |
| 2019 | -5.6% |
| 2018 | +49.8% |
| 2017 | -18.4% |
| 2016 | +2.1% |
| 2015 | -56.1% |
| 2014 | -45.3% |
| 2013 | +106.8% |
| 2012 | +14.7% |
| 2011 | -50.1% |
| 2010 | +15.8% |
| 2009 | +301.1% |
| 2008 | -88.5% |
| 2007 | -24.8% |
| 2006 | -0.2% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Lost 97% over that stretch · deepest drop along the way 97.2%, not recovered by the end of the data |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 31.7% over that stretch · deepest drop along the way 37.9%, back to its old high 32 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Lost 0.7% over that stretch · deepest drop along the way 22%, back to its old high 4.1 months after the low |
Insider activity
Form 4 filings from 2025-10-31 to 2026-10-31 (25 read): 0 open-market purchases and 5 sales ($3.0M).
| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 3, 2026 | Thomas J McInerney President and CEO; Director, Director | sell | $1.1M |
| May 22, 2026 | Thomas J McInerney President and CEO; Director, Director | sell | $927K |
| May 22, 2026 | Robert P Jr Restrepo Director | sell | $456K |
| Aug 21, 2026 | Gregory S. Karawan EVP and General Counsel | sell | $396K |
| Aug 24, 2026 | Melissa Hagerman EVP and Chief HR Officer | sell | $146K |
Who owns it
Large shareholders (13G filings)
| Vanguard Portfolio Management | 6.13% | Mar 31, 2026 |
| DONALD SMITH & CO., INC. | 5.9% | Jun 30, 2026 |
| Vanguard Capital Management | 5.4% | Mar 31, 2026 |
ETFs with the most weight in GNW
| KIE SPDR S&P Insurance ETF | 1.98% |
| RZV Invesco S&P SmallCap 600® Pure Value ETF | 1.44% |
| MYLD Cambria Micro and SmallCap Shareholder Yield ETF | 1% |
| PSCF Invesco S&P SmallCap Financials ETF | 0.88% |
| FYT First Trust Small Cap Value AlphaDEX Fund | 0.52% |
| FLQS Franklin U.S. Small Cap Multifactor Index ETF | 0.41% |
| EBIT Harbor AlphaEdge Small Cap Earners ETF | 0.39% |
| AVUV Avantis U.S. Small Cap Value ETF | 0.33% |
What could go wrong
- Depends on cash from Enact. Genworth relies on dividends and other payments from Enact Holdings to meet its obligations. Enact returned $407 million in 2025. If Enact's results or capital rules limit those payments, Genworth's options shrink.
- Long-term care rate increases may fall short. Raising premiums on old long-term care policies is Genworth's main tool for keeping the Closed Block self-sustaining. These increases need regulators' approval. If approvals fall short, losses on these policies could grow.
- Reserves may need to rise. Reserves are money set aside for future claims on Genworth's long-term care, life and annuity policies, based on assumptions about health and lifespans. If claims differ, Genworth may need to add reserves, cutting earnings.
- A housing slump would hurt Enact. Enact pays lenders when insured borrowers stop paying their mortgages. A severe recession or falling home prices could raise defaults and claims, cutting Enact's profits and the cash it can send to Genworth.
- Fannie Mae and Freddie Mac set the rules. Enact's business is built around loans sold to these two government-sponsored enterprises. If they use less mortgage insurance or raise their capital requirements (called PMIERs), Enact could lose business or be barred from new policies.
- CareScout start-ups may not succeed. Genworth put about $50 million into CareScout Services and $85 million into CareScout Insurance in 2025. These new businesses will take time to grow and may never earn back the money invested.
Recent events
- Executive or board change; Investor presentation or announcement
- Executive or board change
- Executive or board change
- Quarterly results released
- Executive or board change
- Shareholder vote results
- Quarterly results released
- Quarterly results released
- Quarterly results released
- Quarterly results released
For income and retirement investors
Genworth does not pay a dividend. Its dividend yield was 0% as of October 28, 2026. It paid no dividends from fiscal 2021 through fiscal 2025, so there is no payout record or streak of increases to judge. Holding the shares produces no cash income, so an investor who needs income would have to sell shares. Genworth returns cash through buybacks instead. It repurchased $828 million of stock from May 2022 through February 20, 2026, and its share count fell about 25.5% between October 2021 and July 2026. The stock has fallen hard in past downturns. It dropped 97.2% in the 2008 financial crisis and had not regained its 2007 peak as of October 28, 2026. It fell 37.9% in the 2020 COVID crash and took 32 months to recover. In the 2022 bear market it fell 22% and recovered in about 4 months. A single stock carries more risk than a diversified fund.
Questions investors ask
Does Genworth Financial pay a dividend?
No. Genworth's dividend yield was 0% as of October 28, 2026, and the company paid no dividends from fiscal 2021 through fiscal 2025. It returns cash to shareholders through share buybacks instead. It repurchased $828 million of stock between May 2022 and February 20, 2026. In September 2025, its board approved a new buyback program of up to $350 million. Buybacks raise each remaining share's claim on earnings, but they pay holders no cash income.
How does Genworth Financial make money?
Genworth makes money mainly from insurance. Its Closed Block segment holds long-term care, life insurance and annuity policies it no longer sells. That segment produced $5.96 billion, or 81.6% of fiscal 2025 revenue of $7.3 billion. Its Enact segment sells private mortgage insurance, which protects lenders on low down payment home loans. Enact produced $1.25 billion, or 17.1%. Smaller start-ups under the CareScout name sell aging-care services and new long-term care insurance. Net income was $223 million in fiscal 2025.
What is the relationship between Genworth and Enact (ACT)?
Genworth is Enact's parent company. Enact Holdings trades on Nasdaq as ACT, but Genworth controls it through an indirect majority voting interest, so Enact's results are included in Genworth's. Enact is a key source of cash for Genworth. It returned $407 million to Genworth Holdings, a wholly owned Genworth subsidiary, in 2025. That cash helps fund CareScout, buybacks and debt reduction. Genworth's annual report lists its reliance on payments from Enact as a risk.
Does Genworth still sell long-term care insurance?
Yes, through a new company. In October 2025, Genworth stopped selling long-term care insurance through Genworth Life Insurance Company. It launched a new policy, Care Assurance, through CareScout Insurance, and the policy was available in 40 states as of February 20, 2026. Genworth says it priced the product conservatively to reduce the need for future premium increases. Older policies stay in the Closed Block. There, approved rate increases and benefit cuts from 2012 through 2025 produced an estimated $34.5 billion of economic benefit on a net present value basis.
How has Genworth stock performed over the long run?
It has been mixed. As of October 28, 2026, the share price had gained an average of 15.6% a year over five years and 8.4% a year over ten years. Over its longer history, the stock lost 97.2% in the 2008 financial crisis and had not regained its 2007 peak by that date. In the year to October 28, 2026, its largest drop from a high was 16.8%. On that date the shares traded at about 16.4 times fiscal 2025 earnings.